3-186080081-G-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_004454.3(ETV5):āc.386C>Gā(p.Ser129Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000222 in 1,348,846 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 32)
Exomes š: 0.0000022 ( 1 hom. )
Consequence
ETV5
NM_004454.3 missense
NM_004454.3 missense
Scores
1
5
13
Clinical Significance
Conservation
PhyloP100: 5.02
Genes affected
ETV5 (HGNC:3494): (ETS variant transcription factor 5) Enables DNA-binding transcription activator activity, RNA polymerase II-specific and RNA polymerase II transcription regulatory region sequence-specific DNA binding activity. Involved in cellular response to oxidative stress; negative regulation of transcription by RNA polymerase II; and positive regulation of transcription by RNA polymerase II. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22555622).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ETV5 | NM_004454.3 | c.386C>G | p.Ser129Cys | missense_variant | 7/13 | ENST00000306376.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ETV5 | ENST00000306376.10 | c.386C>G | p.Ser129Cys | missense_variant | 7/13 | 1 | NM_004454.3 | P1 | |
ETV5-AS1 | ENST00000453370.1 | n.173-479G>C | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD3 exomes AF: 0.0000131 AC: 2AN: 152380Hom.: 0 AF XY: 0.0000239 AC XY: 2AN XY: 83560
GnomAD3 exomes
AF:
AC:
2
AN:
152380
Hom.:
AF XY:
AC XY:
2
AN XY:
83560
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000222 AC: 3AN: 1348846Hom.: 1 Cov.: 34 AF XY: 0.00000453 AC XY: 3AN XY: 662750
GnomAD4 exome
AF:
AC:
3
AN:
1348846
Hom.:
Cov.:
34
AF XY:
AC XY:
3
AN XY:
662750
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2024 | The c.386C>G (p.S129C) alteration is located in exon 7 (coding exon 6) of the ETV5 gene. This alteration results from a C to G substitution at nucleotide position 386, causing the serine (S) at amino acid position 129 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;T;T;T;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;.;.;.
MutationTaster
Benign
D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N;N
REVEL
Benign
Sift
Benign
T;T;T;D;T
Sift4G
Uncertain
D;D;T;T;.
Polyphen
P;P;.;.;.
Vest4
MutPred
Loss of glycosylation at S129 (P = 0.002);Loss of glycosylation at S129 (P = 0.002);Loss of glycosylation at S129 (P = 0.002);Loss of glycosylation at S129 (P = 0.002);Loss of glycosylation at S129 (P = 0.002);
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at